A clinical trial is set to begin that tests a direct form of gene editing with Crispr to correct inherited malfunctioning genes causing sickle cell disease. . . . → Read More: Trial to Test Direct Crispr Blood Stem Cell Edits
|
|||||
|
       
  |
The start-up enterprise Bluu Biosciences is underway creating seafood products from fish stem cells, and raising $US 8.25 million in seed funds. . . . → Read More: Cell-Based Fish Company Gains $8.25M in Seed Funds  Comments are closed  Finance, New products  agriculture, biotechnology, economics, entrepreneurs, equity, Europe, investment, life sciences, manufacturing, stem cells, venture capital 
A company providing specialized lab and manufacturing services for cell and gene therapy developers is raising $525 million in its third venture funding round. . . . → Read More: Biotech Manufacturer Gains $525M in New Funds Comments are closed Finance biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, manufacturing, pharmaceuticals, stem cells, university, venture capital 
Tests with lab mice show the feasibility of editing genes in blood-forming stem cells in bone marrow as a potential treatment for sickle cell disease. . . . → Read More: In-Body Gene Editing Tested as Sickle Cell Treatment Comments are closed New products biomedical, biotechnology, genomics, life sciences, nanotechnology, pharmaceuticals, preclinical, stem cells 
An ALS treatment developer says the Food and Drug Administration advised the company’s clinical trial data would likely not support approval for patient use. . . . → Read More: ALS Trial Results Deemed Insufficient for FDA Approval Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, FDA, life sciences, pharmaceuticals, stem cells 
A company developing regenerative therapies with engineered stem cells for cancer and other diseases is raising $587.5 million in its initial public offering or IPO. . . . → Read More: Engineered Cell Therapy Company Issues $588M IPO One comment - (Comments are closed) Finance biomedical, biotechnology, equity, genomics, investment, IPO, life sciences, pharmaceuticals, preclinical, stem cells, university 
A biotechnology enterprise is licensing research from Stanford University on messenger RNA to produce proteins that rejuvenate cells damaged by aging. . . . → Read More: Biotech Licenses mRNA Technology for Aging One comment - (Comments are closed) Intellectual property biomedical, biotechnology, entrepreneurs, genomics, licensing, life sciences, pharmaceuticals, preclinical, stem cells, university 
Results of a clinical trial show stem cells from umbilical cord linings help patients with severe respiratory disease recover and survive from Covid-19 infections. . . . → Read More: Stem Cells Help Severe Covid-19 Cases Recover One comment - (Comments are closed) New products biomedical, clinical trials, Covid-19, life sciences, pharmaceuticals, stem cells, university 
A start-up biotech company says it received clearance from the Food and Drug Administration to begin a clinical trial of its gene therapy for Krabbe disease. . . . → Read More: Trial OKed for Rare Disease Gene Therapy Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, entrepreneurs, FDA, genomics, life sciences, manufacturing, pharmaceuticals, stem cells, university 
Results from an early clinical trial of stem cells to treat amyotrophic lateral sclerosis, or ALS, shows the therapy is safe and slows progression of the disease. . . . → Read More: ALS Stem Cell Treatments Found Safe, Slow Progression Comments are closed New products biomedical, biotechnology, clinical trials, Israel, life sciences, pharmaceuticals, stem cells, university |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||